Correction: The deubiquitylase USP9X controls ribosomal stallingAnne Clancy, Michael J. Clague, Sunkyu Kim et al.|The Journal of Cell Biology|2021Cited by 6
Abstract 2894: NTX-452: a non-covalent, potent, selective and highly efficacious WRN inhibitor with best-in-class potential for the treatment of MSI-H tumorsRobert Svensson, Peter J. Tummino, Scott Boiko et al.|Cancer Research|2025Cited by 5
Discovery and characterization of novel inhibitors of CTP synthase 1 (CTPS1) for the treatment of autoimmune and inflammatory diseaseJoshua McElwee, Peter J. Tummino, Neelu Kaila et al.|The Journal of Immunology|2023Cited by 2
Structurally Enabling ADMET Anti-Targets via Induced Fit Docking and Free Energy PerturbationHowook Hwang, Edward B. Miller, Mee Shelley et al.|ChemRxiv|2026Cited by 0
Accelerating Lead Optimization away from Anti-Targets: Navigating the Structural Complexity of Promiscuous ADMET ProteinsHowook Hwang, Edward B. Miller, Mee Shelley et al.|ChemRxiv|2026Cited by 0